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mRNA was abrogated by the addition of cycloheximide. Stimu-Expression of inter--trypsin inhibitor and tumor necrosis fac-
lation of TSG-6 by either IL-1 or 25 mmol/L d-glucose wastor-stimulated gene 6 in proximal tubular epithelial cells.
associated with an inhibition of total percentage plasmin activ-Background. Our previous studies have demonstrated that
ity. Immunoprecipitation of TSG-6 in these samples returnedrenal proximal tubular epithelial cells (PTCs) may contribute
plasmin activity to control levels.to renal interstitial fibrosis by the generation of transforming
Conclusions. The data demonstrate that human PTCs con-growth factor-1 (TGF-1). In these in vitro experiments,
stitutively express the bikunin and H3 components of the IITGF-1 was, however, secreted in its latent form. Plasmin
family of serum protease inhibitors. Moreover, the addition ofhas been implicated as a potential physiological activator of
IL-1 or 25 mmol/L d-glucose up-regulates the expression ofTGF-1. The inter--trypsin inhibitor (II) family of serum
TSG-6 in these cells, resulting in an inhibition of plasmin ac-protease inhibitors together with tumor necrosis factor-stimu-
lated gene 6 (TSG-6) recently have been implicated in the tivity.
regulation of this protease pathway. The aim of the current
study was to examine PTC synthesis of these proteins and to
relate it to alterations of plasmin-protease activity.
The progression of renal disease is correlated with theMethods. PTCs were grown to confluence and stimulated
degree of renal interstitial fibrosis. We and others haveunder serum-free conditions with either interleukin-1 (IL-1)
or 25 mmol/L d-glucose. Alterations in II and TSG-6 genera- previously demonstrated that epithelial cells of the proxi-
tion were detected by Western analysis of both membrane mal tubular epithelial cell (PTC) have the potential to
extracts and supernatant samples. Alterations in gene expres- contribute to the pathogenesis of renal fibrosis directlysion were examined by reverse transcription-polymerase chain
by alterations in the production of components of thereaction. The effect of alteration in synthesis of TSG-6 on
extracellular matrix and indirectly by the production ofplasmin activity was determined by quantitating plasmin inhibi-
tory activity of supernatant samples by in vitro calorimetric profibrotic cytokines [1–3]. Transforming growth factor
assay prior to and following TSG-6 immunoprecipitation. 1 (TGF-1) is a key cytokine implicated in the patho-
Results. The data demonstrate that human PTCs constitu- genesis of fibrosis in both glomerular and interstitial com-tively express mRNA for bikunin and heavy chain 3 (H3) of
partments [4, 5]. We have used the PTC as a model toII. Neither IL-1 (1 ng/mL) nor 25 mmol/L d-glucose influ-
study the mechanisms controlling the generation of thisenced their mRNA expression nor protein synthesis. In con-
trast, the addition of either IL-1 or 25 mmol/L d-glucose key cytokine and have demonstrated that elevated glu-
increased TSG-6 mRNA expression. This was accompanied by cose concentration induced TGF-1 gene expression.
an early up-regulation of TSG-6 protein expression following TGF-1 synthesis was only seen following the furtherIL-1 stimulation (24 h) and a late up-regulation after the
addition of interleukin-1 (IL-1). In these experiments,addition of 25 mmol/L d-glucose (96 h) in the cell culture
TGF-1 was, however, generated in its latent form.supernatant and associated with the cell membranes. Early
induction of TSG-6 mRNA by IL-1 was unaffected by the The mechanisms by which latent TGF-1 is activated
addition of the protein synthesis inhibitor cycloheximide. In physiologically are not well understood. In vitro activa-
contrast, the later glucose-stimulated induction of TSG-6 tion may be achieved by extremes of pH or heat, al-
though it is unlikely that these represent important acti-
vation mechanisms in vivo. Recent studies suggest thatKey words: plasmin, kidney, interstitial fibrosis, transforming growth
factor-, bikunin, protease inhibitors, progressive renal disease. activation of TGF-1 by proteases, particularly cell-asso-
ciated plasmin [6], may be important in vivo, althoughReceived for publication October 4, 2000
other mechanisms also probably exist [7].and in revised form January 17, 2001
Accepted for publication February 15, 2001 The inter--trypsin inhibitor (II) family is a group of
serum protease inhibitors that binds to proteases with a 2001 by the International Society of Nephrology
126
Janssen et al: II and TSG-6 in HPTCs 127
Fig. 1. Current view of the structure of the
II family of protease inhibitors.
weaker affinity than other, more abundant serum inhibi- genes] [10] were cultured in Dulbecco’s modified Eagle’s
medium (DMEM)/Ham’s F12 (Life Technologies, Pais-tors. This family includes four plasma proteins: free bi-
kunin, II, pre--inhibitor (preI) and inter--like inhib- ley, UK) supplemented with 10% fetal calf serum (FCS;
Biological Industries Ltd., Cumbernauld, UK), gluta-itor (ILI; Fig. 1). Each of the last three proteins exists
as distinct assembly of one bikunin chain with one or mine (Life Technologies Ltd.), HEPES buffer (GIBCO
BRL, Paisley, UK), insulin, transferrin, and sodium sele-more unique heavy (H) chains designated H1, H2, and
H3. The three H chains and the bikunin chain are en- nite (Sigma, Poole, UK). Cells were grown at 37C in
5% CO2 and 95% air. Fresh growth medium was addedcoded by four distinct mRNAs. The bikunin component,
which carries an 8 kD chondroitin sulfate chain, is re- to cells every three to four days until confluent. Cells
were grown to confluence and serum deprived for 72sponsible for the protease inhibitory activity of these
family members. A unique feature of these protease hours prior to experimental manipulation. All experi-
ments were performed under serum-free conditions.inhibitors is their ability to inhibit both soluble and cell-
receptor–bound plasmin activity [8]. Despite low intrinsic Selective experiments with primary HPTCs were per-
formed to confirm key observations obtained in HK2plasmin inhibitory activity, the interaction of the bikunin
component with tumor necrosis factor-stimulated gene 6 cells. HPTCs were isolated from normal tissue obtained
from nephrectomy specimens, characterized as pre-(TSG-6) potentiates the plasmin inhibitory activity [9].
This study investigated the regulation of II and TSG-6 viously described [1] and grown under the same culture
conditions as HK2 cells.synthesis by PTCs. In addition, we have examined how
alterations in their synthesis influence plasmin inhibitory
Examination of II and TSG-6 gene expressionactivity. The data demonstrate, to our knowledge for
the first time, that human PTCs (HPTCs) constitutively Confluent growth-arrested monolayers of HK2 cells
or HPTCs were stimulated with either IL-1 (1 ng/mL)express bikunin and H3 components of the II family
of serum protease inhibitors. Moreover, the addition of or 25 mmol/L d-glucose in the absence of serum. In control
experiments, cells were exposed to either 5 mmol/LIL-1 or 25 mmol/L d-glucose up-regulates the expres-
sion of TSG-6 in these cells, resulting in an inhibition of d-glucose or 25 mmol/L l-glucose as the “normal glu-
cose” and “hyperosmolar” controls, respectively. Totalplasmin activity.
cellular RNA was extracted, and gene expression of com-
ponents of the II family of proteins and TSG-6 was
METHODS
examined at various time points up to 96-hours poststi-
Cell culture mulation by reverse transcription (RT) and polymerase
chain reaction (PCR) amplification as previously de-HK2 cells [human renal PTCs immortalized by trans-
duction with human papilloma virus (HPV) 16 E6/E7 scribed [1]. PCR amplification was performed over a
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Table 1. The sequences of the polymerase chain reaction (PCR) amplification primers
Gene Primers Product size Reference
-actin 5-CCTTCCTGGGCATGGAGTCCT-3 204 bp [35]
5-GGAGCAATGATCTTGATCTT-3
TSG-6 5-GGTGTGTACCACAGAGAAGCA-3 284 bp [36]
5-GGGTTGTAGCAATAGGCATCC-3
Bikunin 5-CGTTGGCGGAAAGGTGTCTGTG-3 399 bp [21]
5-ACCCCCTGATCCTTCCTCTTCT-3 
H1 5-AAGCTAAGGGGCCAGAGGACA-3 379 bp [21]
5-TACGGGGACTTGGCACTTAGC-3
H3 5-AGTACCCCGAGAACGCTATCCTG-3 411 bp [21]
5-TGGCCCTCTCATCCTCGTTGTCC-3
range of cycle numbers (26 to 38) to ensure that the solution was drained, and the resin was washed with a
amplification was in the linear range of the curve. One further 15 mL of coupling buffer. Uncoupled sites on
tenth of the PCR reaction from both test and control the resin were then blocked using cysteine (50 mmol/L
(-actin) product was mixed and separated by flat-bed in coupling buffer). The resin was again washed with 15
electrophoresis in 3% wt/vol NuSieve GTG agarose gels mL coupling buffer, followed by 80 mL 1% acetic acid
(Flowgen Instruments Ltd., Sittingbourne, UK), stained and 80 mL NaCl. Finally, the peptide (Cys136-Gly150)-
with ethidium bromide (Sigma), and photographed. The affinity resin was washed with 50 mL 0.05% NaN3 and
negatives were scanned using a densitometer (Model 620 stored in the dark at 4C. Prior to purification of the
video densitometer; Bio-Rad Laboratories Ltd., Hemel- antipeptide (Cys136-Gly150) antibodies, the column was
hempstead, UK) and the density of the bands compared washed with 40 mL phosphate-buffered saline (PBS).
with those of the housekeeping gene. The antiserum was then pumped through the column at
The role of protein synthesis in either IL-1 or 25 room temperature at 1 mL/h. The resin was washed
mmol/L d-glucose induction of TSG-6 mRNA was deter- with 80 mL PBS, followed by 80 mL 1 mol/L NaCl in
mined by stimulation of confluent growth-arrested phosphate buffer, and finally 40 mL PBS. The bound
monolayers of HK2 cells with either IL-1 (1 ng/mL) or antibodies were eluted with 0.1 mol/L glycine (pH 2.8),
25 mmol/L d-glucose in the presence of cycloheximide and the eluate was collected as 2 mL fractions. The frac-
(5 g/mL). Our previous studies have demonstrated that tions were immediately neutralized by adding 100 L
at this dose, cycloheximide inhibits protein synthesis in 1 mol/L Tris/HCl (pH 9.5), and the optical density (OD)
the absence of cell toxicity, as assessed by quantitation of the neutralized fractions was read at 280 nm. The
of total cellular adenosine 5-triphosphate (ATP) [11]. fractions containing protein were pooled and extensively
Total cellular RNA was extracted, and gene expression dialyzed against PBS at 4C. Finally, the OD was read
of TSG-6 mRNA was examined by RT-PCR using spe-
at 280 nm to calculate the protein content, and aliquots
cific oligonucleotide primers at time points of up to 72-
were stored at 70C. The specificity of the antibody washours poststimulation as described previously in this arti-
confirmed by its ability to detect recombinant TSG-6cle (Table 1).
(gift from Dr. Wisniewski, New York, NY, USA) and
TSG-6 in whole serum and synovial fluid by WesternGeneration and purification of TSG-6 antibody
analysis (data not shown).Antibodies against a synthetic peptide of TSG-6 (CGG
VFTDPKRIFKSPG, residue 136 to 150) were raised in Examination of II and TSG-6 protein expression
rabbits. The antiserum was subsequently purified using
Confluent growth-arrested monolayers of HK2 cellsSulfolink-coupling gel (Pierce, Rockford, IL, USA).
were stimulated with either IL-1 (1 ng/mL) or 25 mmol/LBriefly, 5 mL of Sulfolink resin were packed in a dispos-
d-glucose in the absence of serum. To ensure that II/able column (Bio-Rad), and the column was equilibrated
bikunin was not derived from serum, cells were grown inwith 30 mL coupling buffer [50 mmol/L Tris/HCl, 5 mmol/L
10% FCS from which glycosaminoglycans (and thereforeNa2 ethylenediaminetetraacetic acid (EDTA), pH 8.5].
bikunin) were removed as previously described [12], fol-Five milligrams of the synthetic TSG-6 peptide (Cys136-
lowing seeding until growth arrest. Briefly, FCS was passedGly150) were dissolved in coupling buffer and the resin
over DEAE Sephacel (Pharmacia, Uppsala, Sweden) tooverlaid with the peptide solution. The column was cov-
remove any exogenous bovine glycosaminoglycans/pro-ered with aluminum foil to keep out light, sealed and
teoglycans. The removal of II was confirmed by West-then rotated end to end for 15 minutes. After standing
vertically for 30 minutes in the dark, the excess coupling ern analysis of the deglycosaminoglycated FCS (data not
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shown). In control experiments, cells were exposed to II has been previously demonstrated in human plasma
either 5 mmol/L d-glucose or 25 mmol/L l-glucose. [15, 16]. The antibody recognizes the heavy chains and
Following stimulation of cells, supernatants were col- bikunin of all II family members, as well as II associ-
lected and concentrated eightfold using centricon micro- ated with TSG-6.
concentrators (YM-10; 10,000 molecular weight cutoff;
Amicon, Stonehouse, UK). In parallel experiments fol- Plasmin assay
lowing removal of supernatant, the cell surface expres- Plasmin inhibitory activity of supernatant samples was
sion of II and TSG-6 was examined by Western analysis determined by calorimetric assay using H-D-valyl-L-leucyl-
of cell membrane isolates. Preparations of HK2 cell
L-lysine-p-nitroaniline dihydrochloride (Chromogenix,membranes were performed as previously described [13].
Milan, Italy) as a chromogenic substrate as previouslyBriefly, cells were washed three times in PBS and scraped
described [9]. Briefly, nonconcentrated cell supernatantsoff the flasks into 6 mL PBS containing a cocktail of
were preincubated with plasmin (Sigma) for 10 minutesproteinase inhibitors [pepstatin A, aprotinin, and leu-
at 37C to allow the formation of plasmin inhibitor com-peptin at 10 g/mL, and phenylmethylsulfonyl fluoride
plexes. Subsequently, the chromogenic substrate was(PMSF) at 174 g/mL; all purchased from Sigma]. Cells
added, and the reaction mixtures were incubated at 37Cwere pelleted by centrifuging at 500  g for 10 minutes
for 10 minutes. The reaction was stopped by the additionat 4C. The cell pellet was subsequently resuspended in
of acetic acid, and the degree of proteolysis was deter-0.4 mL hypotonic buffer (10 mmol/L Tris, 1 mmol/L
mined by measuring adsorbance at 405 nm. The finalMgCl2, pH 7.2, containing the protease inhibitor cocktail)
and mixed with four volumes of sucrose buffer (0.25 concentrations in the assay were 0.7 mmol/L H-D-valyl-
mol/L sucrose dissolved in hypotonic buffer). Mem- L-leucyl-L-lysine-p-nitroaniline dihydrochloride and 0.07
branes were homogenized by 50 strokes in a dounce CU/mL plasmin. Each supernatant sample was measured
pestle and centrifuged at 500  g for five minutes at in duplicate, and the OD values obtained normalized to
4C to remove nuclei and unbroken cells. A membrane- the time zero medium control for each experimental
enriched fraction was obtained by centrifuging the super- condition.
natant at 25,000  g for 30 minutes at 4C. The resulting
membrane pellets were resuspended in PBS containing Immunoprecipitation of TSG-6
1 mmol/L PMSF. The protein content of the samples
Confirmation that alterations in TSG-6 were responsi-was determined using the Bio-Rad protein assay (Bio-
ble for changes in plasmin inhibitory activity was soughtRad Laboratories GmbH, Mu¨nchen, Germany) using
by repeating plasmin assays following TSG-6 immuno-bovine serum albumin (Sigma) as a standard.
precipitation. Briefly, cell supernatants were preclearedIn all experiments, expression of II and TSG-6 fol-
with 50 L packed protein A cross-linked 4% beadedlowing stimulation was examined by Western analysis.
agarose (Sigma) at 4C for one hour. The beads wereBriefly, equal amounts of cell membrane protein were
removed by centrifugation (13,000 r.p.m., 5 sec), and theloaded onto 3 to 12% sodium dodecyl sulfate-polyacryl-
supernatant was collected; 10.5 g of purified polyclonalamide (SDS-PAGE) gradient gels and electrophoresis
rabbit anti–TSG-6 antibody (discussed previously in thiscarried out under reducing conditions according to the
procedure of Laemmli [14]. After electrophoresis, the article) or purified rabbit IgG (Sigma) as a control was
separated proteins were transferred to a nitrocellulose added to each 500 L of the cleared supernatant and
membrane (Amersham, Little Chalfont, Buckingham- incubated at 4C with constant mixing for 12 hours. The
shire, UK). The membrane was blocked with Tris-buf- immune complex was captured by the addition of packed
fered saline containing 5% nonfat powdered milk for agarose protein A beads (100 L/500 L supernatant)
one hour and then incubated with either rabbit anti- for two hours at 4C. Separation of the beads was
human II (Dako, Glostrup, Denmark) or purified poly- achieved by centrifugation (13,000  g for 5 min), and
clonal rabbit anti–TSG-6 antibody raised against a syn- the supernatant was removed. Plasmin assay of the cell
thetic peptide of TSG-6 (discussed previously in this supernatants following immunoprecipitation was then
article) in Tris-buffered saline containing 1% bovine se- performed, and results were compared with supernatant
rum albumin and 0.05% Tween 80 (Tris-buffered saline-
aliquots from the same experiments that had not under-Tween) for one hour at room temperature. The blots
gone TSG-6 immunoprecipitation.were subsequently washed in Tris-buffered saline-Tween
and then incubated with goat anti-rabbit horseradish per-
Statistical analysisoxidase-conjugated antibody (Sigma) in Tris-buffered
Values are expressed as mean  SD. Values are com-saline-Tween. Proteins were visualized using enhanced
pared using the Student t test. Statistical significance waschemiluminescence (Amersham) according to the manu-
facturer’s instructions. The specificity of the antihuman defined as P 	 0.05.
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Fig. 2. Constitutive expression of bikunin
and H3 mRNA. Growth-arrested HK2 cells
were stimulated with 5 mmol/L d-glucose, 25
mmol/L d-glucose, or interleukin (IL)-1 (1
ng/mL) in the absence of serum. Total cellular
RNA was isolated and mRNAs for bikunin
(A) and heavy chain 3 (H3) mRNA (B) exam-
ined by RT-PCR (36 cycles of amplification).
Ethidium bromide stained PCR products were
separated on a 3% agarose gel. Scanning den-
sitometry confirmed the lack of induction of
either bikunin or H3 mRNA expression in
the presence of either IL-1 or 25 mmol/L
d-glucose. One representative gel of four indi-
vidual experiments is shown.
RESULTS influenced by addition of either IL-1 or 25 mmol/L
d-glucose (Fig. 3).Regulation of II: Constitutive expression of
bikunin and H3
Induction of TSG-6 mRNA and protein by
Confluent monolayers of growth-arrested HK2 cells IL-1 and glucose
demonstrated constitutive expressions of bikunin and
Stimulation of growth-arrested monolayers of HK2H3 mRNA of II. The addition of either IL-1 or 25
cells with either IL-1 or 25 mmol/L d-glucose led tommol/L d-glucose to confluent monolayers of HK2 cells
induction of TSG-6 mRNA. This was apparent 3 hoursdid not influence bikunin or H3 gene expression (Fig.
after the addition of IL-1, but only 48 hours after the2). Similarly, the addition of either IL-1 or 25 mmol/L
addition of 25 mmol/L d-glucose (Fig. 4A). Induction ofd-glucose to confluent monolayers of HPTCs did not
TSG-6 mRNA was also detected following stimulationstimulate expression of the mRNA of II components
of HPTCs by either IL-1 or 25 mmol/L d-glucose (Fig.(bikunin and H3 chains; data not shown). No expression
4B). Increased expression of TSG-6 mRNA in HPTCsof H1 chain mRNA of II was detected in either stimu-
showed similar kinetics to that seen in HK-2 cells, withlated or unstimulated HK2 or HPTCs by RT-PCR with
delayed up-regulation in the presence of 25 mmol/Lan amplification up to 42 cycles (liver homogenates
d-glucose relative to that seen after IL-1 stimulation.served as positive controls).
The induction of TSG-6 mRNA by either stimulationWestern blot analysis confirmed the constitutive ex-
by IL-1 or addition of 25 mmol/L d-glucose was accom-pression of proteins of the II family in the membrane
extracts of HK2 cells. None of the components were panied by an increase in TSG-6 protein expression in
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While IL-1–induced TSG-6 mRNA up-regulation was
not influenced by cycloheximide, the effect of 25 mmol/L
d-glucose was abrogated by cycloheximide (Fig. 7). This
observation suggests that 25 mmol/L d-glucose can exert
a stimulatory effect on TSG-6 synthesis via de novo pro-
tein synthesis.
Inhibition of plasmin activity
Stimulation of HK2 cells by IL-1 resulted in an early
increase in plasmin inhibitory activity of cell superna-
tants (Fig. 8). The later stimulation of TSG-6 following
the addition of 25 mmol/L d-glucose was associated with
increased plasmin inhibitory activity at these later time
points (Fig. 8A). A similar pattern of increased in plas-
min inhibitory activity was seen following stimulation of
HPTCs with IL-1 or 25 mmol/L d-glucose (Fig. 8B).
To confirm that the inhibition of plasmin activity of su-
pernatants from either HK2 cells or HPTCs stimulated
with either IL-1 or 25 mmol/L d-glucose was dependent
on the stimulation of TSG-6 synthesis, TSG-6 immuno-
precipitation was performed and plasmin activity was
quantitated. Immunoprecipitation of TSG-6 resulted in
removal of all plasmin inhibitory activity from both HK-2
(Fig. 9A) and HPTC culture supernatants. Immunopre-Fig. 3. Protein expression of the inter-alpha-trypsin inhibitor (II)
family in membrane isolates of HK2 cells. Growth-arrested HK2 cells cipitation with rabbit IgG had no effect on plasmin inhib-
were stimulated with either 5 mmol/L d-glucose (5 Gl) or IL-1 (1 ng/ itory activity.mL) for up to 24 hours in the absence of serum. Membrane preparations
were isolated, and equal amounts of HK2-derived membrane protein
(19 g/lane) were loaded onto 3 to 12% SDS-PAGE gradient gels.
DISCUSSIONWestern blot analysis was carried out as detailed in the Methods section.
In parallel experiments, growth-arrested cells were stimulated with ei- Previously, we have demonstrated that the co-opera-ther 5 mmol/L d-glucose (5 Gl), 25 mmol/L d-glucose (25 Gl), or 25
tive effects of the proinflammatory cytokine IL-1 andmmol/L l-glucose (25 L-Gl), for up to 96 hours. The antiserum used
recognizes intact II family members [including pre-I (120 to 130 elevated d-glucose concentrations stimulate the synthe-
kD)], individual heavy chains (75 to 80 kD), and bikunin (35 kD), as sis of TGF-1, predominately in its latent form [2]. Towell as II associated with TSG-6 (TSG-6, molecular weight 42 kD). The
date, the mode of activation of TGF-1 in vivo remainsmultiple bands following Western analysis therefore represent intact II
family members, individual chains of II, and complexes bound to TSG- unclear, although increasing evidence suggests that pro-
6 [18]. Scanning densitometry confirmed that there were no differences teolytic activation by plasmin may represent one physio-in II expression under any of the experimental conditions. One repre-
logically important mechanism [17]. A recent study dem-sentative experiment of four independent experiments is shown.
onstrated that the interactions between II and TSG-6
potentiate the inhibitory effect of II on plasmin activity
[9]. We speculate that modification of plasmin activity
the membrane extracts and supernatants of HK2 cells, by II/TSG-6 may subsequently influence the activation
as detected by Western analysis (Figs. 5 and 6). Twenty- of TGF-. As a first step aimed at understanding the
five mmol/L l-glucose, serving as an osmotic control, did mechanisms that underlie the generation of TGF-1 in
not induce TSG-6 mRNA (data not shown) nor protein its latent form, we have examined the regulation of II
expression (Fig. 6). and TSG-6 generation by renal proximal tubular cells,
in response to the stimuli previously implicated in induc-
Induction of TSG-6 mRNA by IL-1 is regulated via tion of TGF-1 synthesis, namely IL-1 and 25 mmol/L
a protein synthesis-independent pathway d-glucose.
To assess whether the IL-1 and 25 mmol/L d-glu- The data demonstrate that HPTCs constitutively ex-
cose–induced TSG-6 mRNA expression was dependent press components of the II family of serum protease
on de novo protein synthesis, HK2 cells were stimulated inhibitors and that their expression was not influenced
with either 1 ng/mL of IL-1 or 25 mmol/L d-glucose in by addition of either IL-1 or 25 mmol/L d-glucose.
the presence of cycloheximide (5 g/mL). The addition Previous studies have demonstrated that the components
of cycloheximide alone did not influence TSG-6 mRNA of the II family are synthesized predominantly in hepa-
tocytes, and during their transport to the cell surface,expression at any of the time points studied (Fig. 7).
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Fig. 4. Induction of tumor necrosis factor-
stimulated gene-6 (TSG-6) mRNA by inter-
leukin-1 (IL-1) or 25 mmol/L D-glucose.
Growth-arrested HK2 cells (A) or HPTCs (B)
were stimulated with 5 mmol/L d-glucose, 25
mmol/L d-glucose, or IL-1 (1 ng/mL) in the
absence of serum. Total cellular RNA was
isolated at various time points up to 96 hours,
and TSG-6 mRNA was examined by RT-PCR.
Ethidium bromide-stained PCR products were
separated on a 3% agarose gel. One represen-
tative gel of four individual experiments is
shown.
the heavy chains become covalently linked to the chon- onto the cell surface through covalent interactions be-
tween their heavy chains and hyaluronic acid [20, 21].droitin sulfate chain of bikunin. To date, little is known
about extra-hepatic synthesis of these components of This interaction is subsequently thought to stabilize the
pericellular matrix. A unique feature of the inhibitionprotease inhibitors. A recent study has demonstrated
increased expression of bikunin mRNA transcripts in of plasmin activity by II is that in addition to inhibiting
soluble plasmin, cell-receptor plasmin activity is also in-whole kidney tissue in response to ethylene glycol-in-
duced hyperoxaluria [18]. Our studies suggest that renal hibited [8]. This inhibitory effect on receptor/cell surface
bound plasmin is in contrast to the more abundant circu-proximal tubular cells produce the preI variant of II,
composed of a single H3 chain associated with bikunin. lating protease inhibitors such as 2-macroglobulin. Re-
cent studies have also demonstrated that plasmin mayAs we have not excluded the possibility that PTCs may
synthesize H2 chains, it remains possible that PTCs may be the physiological activator of latent TGF-1 [17, 22,
23]. Activation of TGF-1 by plasmin is promoted byalso synthesize ILI. Interestingly, it has been postulated
that the II and ILI family members behave as negative the surface localization of plasmin by its receptor [24]
and requires the binding of latent TGF-1 to the plasmaacute-phase proteins, while preI is a positive acute
phase protein [19], its hepatic synthesis being increased membrane [25–27]. This has led to the proposal of a
general model of TGF-1 activation, which involves lo-in patients with acute systemic infections.
Inter--trypsin inhibitor family members are captured calization of TGF-1 to the cell surface and its activation
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Fig. 5. Induction of TSG-6 protein following IL-1 stimulation. Growth-
arrested HK2 cells were stimulated with 5 mmol/L d-glucose (5 Gl) or Fig. 6. Induction of TSG-6 protein following 25 mmol/L D-glucose
IL-1 (1 ng/mL) in the absence of serum. Membrane preparations were stimulation. Growth-arrested HK2 cells were stimulated with 5 mmol/L
isolated at 24-hours poststimulation (A). Equal amounts of PTC-derived d-glucose (5 Gl) or 25 mmol/L d-glucose (25 Gl) or 25 mmol/L l-glucose
membrane protein (18 g/lane) was loaded onto 3 to 12% SDS-PAGE (25 L-Gl). Membrane preparations (A) or supernatant samples (B)
gradient gels. In parallel experiments, supernatants were collected, con- were collected at 72-hours and 96-hours poststimulation, respectively.
centrated, and loaded onto 3 to 12% SDS polyacrylamide gradient gels Equal amounts of PTC-derived membrane protein (19 g/lane) were
(20 L of 8, concentrated supernatant/lane; B). Western blot analysis loaded onto 3 to 12% SDS-PAGE gradient gels. Supernatant were
was carried out as detailed in the Methods section. concentrated using centricon microconcentrators and loaded onto 3 to
12% SDS-PAGE gradient gels (20 L/lane). Western blot analysis was
carried out as detailed in the Methods section.
by cell-associated plasmin [6]. These observations there-
fore suggest that modification of cell surface plasmin
of a stable complex between TSG-6 and II family mem-activity by II may influence the activation of TGF-.
bers [30], which potentiate the plasmin inhibitory activityIn our system, however, it would appear that the synthe-
of the bikunin component of the latter [9]. In contrastsis of II components is not influenced by stimuli that
to bikunin and H3 chains of II, the data in the currentinduce TGF-1 synthesis.
study demonstrate that TSG-6 expression in PTCs wasTumor necrosis factor-stimulated gene 6 is a recently
up-regulated upon stimulation with either IL-1 or 25identified member of the family of the hyaluronan-bind-
mmol/L d-glucose. Furthermore, this was associated withing proteins [28]. Inducible expression of TSG-6 by pro-
reduced plasmin activity. This observation cannot be ex-inflammatory cytokines has been demonstrated previously
plained by the induction or inhibition of factors that con-in human synoviocytes, and the presence of increased
trol the generation of plasmin from plasminogen, sincelevels of its protein in the synovial fluids of arthritis
the assay measures the activity of exogenous added plas-patients has suggested a role in inflammation [29]. It
min. Furthermore, the immunoprecipitation of TSG-6is now clear that TSG-6 has potent anti-inflammatory
actions both in vitro and in vivo through the formation from the samples removed all plasmin inhibitory activity,
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Fig. 7. Effect of cycloheximide upon the IL-1
and 25 mmol/L D-glucose–induced TSG-6
mRNA. Growth-arrested HK-2 cells were
stimulated with IL-1 (1 ng/mL) in the pres-
ence or absence of cycloheximide (5 g/mL)
for up to 24 hours. Similarly, growth-arrested
cells were stimulated with 25 mmol/L d-glu-
cose in the presence or absence of cyclohexi-
mide (5 g/mL) for up to 72 hours prior to
isolation of total cellular RNA. In addition,
RNA was isolated from unstimulated control
cells at time zero, and cells were incubated
with cycloheximide alone at time points up to
72 hours. TSG-6 mRNA was examined by RT-
PCR. Subsequently, PCR products were sepa-
rated by electrophoresis on a 3% agarose gel
(A). The results are expressed as the normal-
ized densitometric ratios of TSG-6 mRNA to
-actin following stimulation with either 25
mmol/L d-glucose or IL-1 (1 ng/mL) in the
absence of cycloheximide () to the ratio fol-
lowing stimulation in the presence of cyclo-
heximide () (B). One representative gel of
four individual experiments is shown.
thereby confirming that the inhibition of plasmin activity tion of the II/TSG-6 system, as seen in our study, con-
tributed to the observed net effect on PA activity. Inwas dependent on the stimulation of TSG-6. These re-
sults suggest that stimuli that we have previously demon- contrast, stimulation of human mesangial cells with IL-1
has been reported to down-regulate PAI-1 productionstrated to increase the synthesis of TGF-1 also lead to
an inhibition of one of the potential pathways leading and up-regulate t-PA [32]. However, the net effect of
these changes on plasmin activity was not addressed. Fur-to its activation.
In other cell systems, IL-1 and glucose have been ther studies are therefore needed to investigate the up-
stream events that may regulate plasmin activity in PTCs.implicated in the modulation of plasmin activity by mod-
ulation of the plasminogen activator (PA)/tissue-type A striking finding of our study was the apparent differ-
ence in the kinetics of induction of TSG-6 by IL-1 andplasminogen activator inhibitor (tPA/urokinase) system.
Data obtained in human umbilical vein endothelial cells 25 mmol/L d-glucose. Furthermore, induction of TSG-6
by IL-1 could be distinguished from 25 mmol/L d-glucose(HUVECs) suggest that elevated glucose up-regulates
t-PA as well as PAI-1 expression and production [31]. stimulation of TSG-6 mRNA by the insensitivity of the
former to protein synthesis inhibition by cycloheximide.This resulted in a decrease in PA activity assessed as
the activity of plasmin generated from exogenous added This finding is similar to findings in vascular smooth
muscle cells in which an IL-1 pathway could be distin-plasminogen. It was concluded that this reflected an over-
whelming effect of the increased availability of PAI-1 guished from a growth-factor (epidermal growth factor/
fibroblast growth factor-1) pathway by its insensitivity toover t-PA. However, the expression of protease inhibitors,
such as the II/TSG-6 system, acting directly on the activ- protein synthesis inhibitors [33]. Furthermore, a “growth
factor” cycloheximide-sensitive pathway described in ar-ity of plasmin downstream from plasminogen was not
addressed. Therefore, it cannot be excluded that induc- ticular chondrocytes was also demonstrated to be de-
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Fig. 9. Immunoprecipitation of TSG-6 abrogates plasmin inhibitory
activity in IL-1 and 25 mmol/L D-glucose stimulated cell culture super-
natants. Supernatant samples were collected from HK-2 (A) cells or
HPTCs (B) stimulated with either IL-1 (1 ng/mL) for 24 hours or 25
mmol/L d-glucose for 96 hours. TSG-6 was immunoprecipitated and
plasmin activity measured. Data were normalized to the time zero me-Fig. 8. Inhibition of plasmin activity in supernatants after stimulation
dium control for each experimental condition. Results show the plasminwith IL-1 or 25 mmol/L D-glucose. Growth-arrested HK-2 cells (A)
activity prior () to and following immunoprecipitation with anti-TSG-6or HPTCs (B) were stimulated with 5 mmol/L d-glucose (), 25 mmol/L
antibody () or rabbit IgG control ( ). Values represent the mean d-glucose (), or IL-1 (; 1 ng/mL) in the absence of serum up to
SD of four independent experiments. *P 	 0.05 for TSG-6 immunopre-96 hours. Plasmin activity of supernatants was determined as detailed
cipitated samples vs. nonimmunoprecipitated and rabbit IgG control.in the Methods section. Results were normalized to the time zero
medium control for each experimental condition and the data represents
mean  SD of three independent experiments. *P 	 0.05 IL-1 vs. 5
mmol/L d-glucose; #P 	 0.05 25 mmol/L vs. 5 mmol/L d-glucose.
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APPENDIXAlso shown are two distinct pathways in the proximal
Abbreviations used in this article are: EDTA, ethylenediaminetetra-tubular cell by which TSG-6 synthesis may be stimulated.
acetic acid; FCS, fetal calf serum; H, heavy chain; HK2 cells, humanIn conclusion, these observations suggest that stimuli
renal proximal tubular epithelial cells immortalized by transduction
that modulate the synthesis of the profibrotic cytokine with HPV; HPTC, human proximal tubular epithelial cells; HPV, hu-
man papilloma virus; HUVEC, human umbilical vein endothelial cells;TGF-1 may potentially modulate its activation.
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ILI, inter-alpha-like inhibitor; II, inter-alpha-trypsin inhibitor; IL, quantitative immunoelectrophoresis. II. Pathological conditions.
Clin Chim Acta 162:189–198, 1987interleukin; pre-I, pre-alpha-inhibitor; PBS, phosphate-buffered sa-
17. Lyons RM, Gentry LE, Purchio AF, et al: Mechanism of activa-line; PMSF, phenylmethylsulfonyl fluoride; PTC, renal proximal tubular
tion of latent recombinant transforming growth factor beta1 byepithelial cell; RT-PCR, reverse transcription-polymerase chain reaction;
plasmin. J Cell Biol 110:1361–1367, 1990SDS-PAGE, sodium dodecyl sulfate-polyacrylamide gradient gels and
18. Iida S, Peck AB, Johnson-Tardieu J, et al: Temporal changes inelectrophoresis; TGF-, transforming growth factor-; TSG-6, tumor
mRNA expression for bikunin in the kidneys of rats during calciumnecrosis factor-stimulated gene 6.
oxalate nephrolithiasis. J Am Soc Nephrol 10:986–996, 1999
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